Litcius/Paper detail

Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study

Hussein A Tawbi, Peter A Forsyth, F Stephen Hodi, Alain P Algazi, Omid Hamid, Christopher D Lao, Stergios J Moschos, Michael B Atkins, Karl Lewis, Michael A Postow, Reena P Thomas, John Glaspy, Sekwon Jang, Nikhil I Khushalani, Anna C Pavlick, Marc S Ernstoff, David A Reardon, Ragini Kudchadkar, Ahmad Tarhini, Caroline Chung, Corey Ritchings, Piyush Durani, Margarita Askelson, Igor Puzanov, Kim A Margolin

2021The Lancet Oncology323 citationsDOIOpen Access PDF

Topics & Concepts

IpilimumabMedicineNivolumabInternal medicineOncologyMelanomaImmunotherapyPhases of clinical researchMetastatic melanomaPhase (matter)Adverse effectPembrolizumabBrain Metastases and TreatmentCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management